Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

A variational approach to optimal two-stage designs.

Pilz M, Kunzmann K, Herrmann C, Rauch G, Kieser M.

Stat Med. 2019 Jul 1. doi: 10.1002/sim.8291. [Epub ahead of print]

PMID:
31264243
2.

Introducing a new estimator and test for the weighted all-cause hazard ratio.

Ozga AK, Rauch G.

BMC Med Res Methodol. 2019 Jun 11;19(1):118. doi: 10.1186/s12874-019-0765-1.

3.

[Research involving human subjects-principles and challenges for the work of ethics committees].

Pigeot I, Mansmann U, Rauch G.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jun;62(6):679-681. doi: 10.1007/s00103-019-02961-7. German. No abstract available.

PMID:
31143987
4.

[Current challenges in the assessment of ethical proposals-aspects of digitalization and personalization in the healthcare system].

Rauch G, Röhmel J, Gerß J, Scherag A, Hofner B.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jun;62(6):758-764. doi: 10.1007/s00103-019-02955-5. Review. German.

PMID:
31073662
5.

[The role of biostatistics in institutional review boards].

Schlattmann P, Scherag A, Rauch G, Mansmann U.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jun;62(6):751-757. doi: 10.1007/s00103-019-02951-9. Review. German.

PMID:
31065736
6.

MR staging of anal cancer: what the radiologist needs to know.

Golia Pernicka JS, Sheedy SP, Ernst RD, Minsky BD, Ganeshan D, Rauch GM.

Abdom Radiol (NY). 2019 Apr 30. doi: 10.1007/s00261-019-02020-4. [Epub ahead of print] Review.

PMID:
31041496
7.

Imaging features of triple-negative breast cancers according to androgen receptor status.

Candelaria RP, Adrada BE, Wei W, Thompson AM, Santiago L, Lane DL, Huang ML, Arribas EM, Rauch GM, Symmans WF, Gilcrease MZ, Huo L, Lim B, Ueno NT, Moulder SL, Yang WT.

Eur J Radiol. 2019 May;114:167-174. doi: 10.1016/j.ejrad.2019.03.017. Epub 2019 Mar 21.

PMID:
31005169
8.

Locally recurrent rectal cancer: what the radiologist should know.

Ganeshan D, Nougaret S, Korngold E, Rauch GM, Moreno CC.

Abdom Radiol (NY). 2019 Apr 5. doi: 10.1007/s00261-019-02003-5. [Epub ahead of print]

PMID:
30953096
9.

Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery.

Park KU, Kuerer HM, Rauch GM, Leung JWT, Sahin AA, Wei W, Li Y, Black DM.

Ann Surg Oncol. 2019 Jun;26(6):1720-1728. doi: 10.1245/s10434-019-07226-w. Epub 2019 Mar 14.

PMID:
30877499
10.

Development of Cortical Lesion Volumes on Double Inversion Recovery MRI in Patients With Relapse-Onset Multiple Sclerosis.

Faizy TD, Broocks G, Thaler C, Rauch G, Gebert P, Stürner KH, Flottmann F, Leischner H, Kniep HC, Stellmann JP, Heesen C, Fiehler J, Gellißen S, Hanning U.

Front Neurol. 2019 Feb 22;10:133. doi: 10.3389/fneur.2019.00133. eCollection 2019.

11.

Leukemic Involvement in the Thorax.

Shroff GS, Truong MT, Carter BW, Benveniste MF, Kanagal-Shamanna R, Rauch G, Viswanathan C, Boddu PC, Daver N, Wu CC.

Radiographics. 2019 Jan-Feb;39(1):44-61. doi: 10.1148/rg.2019180069.

PMID:
30620703
12.

A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β.

Yam C, Murthy RK, Rauch GM, Murray JL, Walters RS, Valero V, Brewster AM, Bast RC Jr, Booser DJ, Giordano SH, Esteva FJ, Yang W, Hortobagyi GN, Moulder SL, Arun B.

Invest New Drugs. 2018 Dec;36(6):1103-1109. doi: 10.1007/s10637-018-0672-z. Epub 2018 Oct 11.

PMID:
30311036
13.

What makes a biostatistician?

Zapf A, Huebner M, Rauch G, Kieser M.

Stat Med. 2019 Feb 20;38(4):695-701. doi: 10.1002/sim.7998. Epub 2018 Oct 7.

PMID:
30294934
14.

„Wir sind Orthopädie und Unfallchirurgie“.

Siebert W, Windolf J, Rauch G.

Z Orthop Unfall. 2018 Oct;156(5):511-512. doi: 10.1055/a-0582-7037. Epub 2018 Oct 5. German. No abstract available.

PMID:
30290392
15.

ASO Author Reflections: Elimination of Breast Cancer Surgery in Complete Responders After Neoadjuvant Chemotherapy: Imaging Perspective.

Rauch GM.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):628-629. doi: 10.1245/s10434-018-6780-3. Epub 2018 Sep 22. No abstract available.

PMID:
30244417
16.

RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.

Heil J, Sinn P, Richter H, Pfob A, Schaefgen B, Hennigs A, Riedel F, Thomas B, Thill M, Hahn M, Blohmer JU, Kuemmel S, Karsten MM, Reinisch M, Hackmann J, Reimer T, Rauch G, Golatta M.

BMC Cancer. 2018 Aug 25;18(1):851. doi: 10.1186/s12885-018-4760-4.

17.

A pictorial review: multimodality imaging of benign and suspicious features of fat necrosis in the breast.

Tayyab SJ, Adrada BE, Rauch GM, Yang WT.

Br J Radiol. 2018 Dec;91(1092):20180213. doi: 10.1259/bjr.20180213. Epub 2018 Jul 31. Review.

PMID:
29987981
18.

High risk breast lesions identified on MRI-guided vacuum-assisted needle biopsy: outcome of surgical excision and imaging follow-up.

Speer ME, Huang ML, Dogan BE, Adrada BE, Candelaria RP, Hess KR, Hansakul P, Yang WT, Rauch GM.

Br J Radiol. 2018 Oct;91(1090):20180300. doi: 10.1259/bjr.20180300. Epub 2018 Jul 5.

PMID:
29947265
19.

Cardiac Implantable Electronic Device Interrogation at Forensic Autopsy: An Underestimated Resource?

Lacour P, Buschmann C, Storm C, Nee J, Parwani AS, Huemer M, Attanasio P, Boldt LH, Rauch G, Kucher A, Pieske B, Haverkamp W, Blaschke F.

Circulation. 2018 Jun 19;137(25):2730-2740. doi: 10.1161/CIRCULATIONAHA.117.032367.

PMID:
29915100
20.

Revival of transcatheter PFO closure: A meta-analysis of randomized controlled trials - impact of shunt size and age.

Reinthaler M, Ozga AK, Sinning D, Curio J, Al-Hindwan HS, Bäckemo Johansson J, Jung F, Lendlein A, Rauch G, Landmesser U.

Am Heart J. 2018 Jul;201:95-102. doi: 10.1016/j.ahj.2018.03.025. Epub 2018 Apr 6. Review.

PMID:
29910060
21.

The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?

Rauch G, Brannath W, Brückner M, Kieser M.

Methods Inf Med. 2018 May;57(3):89-100. doi: 10.3414/ME17-01-0058. Epub 2018 May 2.

PMID:
29719915
22.

Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints.

Rauch GM, Kuerer HM, Adrada B, Santiago L, Moseley T, Candelaria RP, Arribas E, Sun J, Leung JWT, Krishnamurthy S, Yang WT.

Ann Surg Oncol. 2018 Jul;25(7):1953-1960. doi: 10.1245/s10434-018-6481-y. Epub 2018 Apr 17.

PMID:
29667115
23.

Hepatitis E seroprevalence in the Americas: A systematic review and meta-analysis.

Horvatits T, Ozga AK, Westhölter D, Hartl J, Manthey CF, Lütgehetmann M, Rauch G, Kriston L, Lohse AW, Bendall R, Wedemeyer H, Dalton HR, Pischke S.

Liver Int. 2018 Nov;38(11):1951-1964. doi: 10.1111/liv.13859. Epub 2018 May 3.

PMID:
29660259
24.

Comparison of Breast MR Imaging with Molecular Breast Imaging in Breast Cancer Screening, Diagnosis, Staging, and Treatment Response Evaluation.

Rauch GM, Adrada BE.

Magn Reson Imaging Clin N Am. 2018 May;26(2):273-280. doi: 10.1016/j.mric.2017.12.009. Review.

PMID:
29622132
25.

MR Imaging of Primary Chest Wall Neoplasms.

Bueno J, Lichtenberger JP 3rd, Rauch G, Carter BW.

Top Magn Reson Imaging. 2018 Apr;27(2):83-93. doi: 10.1097/RMR.0000000000000164. Review.

PMID:
29613963
26.

Baseline factors predicting a response to neoadjuvant chemotherapy with implications for non-surgical management of triple-negative breast cancer.

van la Parra RFD, Tadros AB, Checka CM, Rauch GM, Lucci A Jr, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM.

Br J Surg. 2018 Apr;105(5):535-543. doi: 10.1002/bjs.10755. Epub 2018 Feb 21.

PMID:
29465744
27.

Time-to-first-event versus recurrent-event analysis: points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints.

Rauch G, Kieser M, Binder H, Bayes-Genis A, Jahn-Eimermacher A.

Clin Res Cardiol. 2018 May;107(5):437-443. doi: 10.1007/s00392-018-1205-7. Epub 2018 Feb 16.

PMID:
29453594
28.

Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis.

Schaefgen B, Heil J, Barr RG, Radicke M, Harcos A, Gomez C, Stieber A, Hennigs A, von Au A, Spratte J, Rauch G, Rom J, Schütz F, Sohn C, Golatta M.

Eur Radiol. 2018 Jun;28(6):2499-2506. doi: 10.1007/s00330-017-5235-8. Epub 2018 Jan 4.

PMID:
29302784
29.

A systematic comparison of recurrent event models for application to composite endpoints.

Ozga AK, Kieser M, Rauch G.

BMC Med Res Methodol. 2018 Jan 4;18(1):2. doi: 10.1186/s12874-017-0462-x.

30.

Development and psychometric validation of a shorter version of the Breast Cancer Treatment Outcome Scale (BCTOS-12).

Hennigs A, Heil J, Wagner A, Rath M, Moosbrugger H, Kelava A, Golatta M, Hug S, Riedel F, Rauch G, Feißt M.

Breast. 2018 Apr;38:58-65. doi: 10.1016/j.breast.2017.12.002. Epub 2018 Jan 4.

PMID:
29248875
31.

A weighted combined effect measure for the analysis of a composite time-to-first-event endpoint with components of different clinical relevance.

Rauch G, Kunzmann K, Kieser M, Wegscheider K, König J, Eulenburg C.

Stat Med. 2018 Feb 28;37(5):749-767. doi: 10.1002/sim.7531. Epub 2017 Dec 4.

PMID:
29205425
32.

Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancer.

Safi S, Yamauchi Y, Rathinasamy A, Stamova S, Eichhorn M, Warth A, Rauch G, Dienemann H, Hoffmann H, Beckhove P.

Oncoimmunology. 2017 Sep 8;6(11):e1360458. doi: 10.1080/2162402X.2017.1360458. eCollection 2017.

33.

Optimal Selection of Breast Cancer Patients for Elimination of Surgery Following Neoadjuvant Systemic Therapy.

Kuerer HM, Krishnamurthy S, Rauch GM, Yang WT, Smith BD, Valero V.

Ann Surg. 2018 Dec;268(6):e61-e62. doi: 10.1097/SLA.0000000000002573. No abstract available.

PMID:
29064904
34.

MRI for the Staging and Evaluation of Response to Therapy in Breast Cancer.

Adrada BE, Candelaria R, Rauch GM.

Top Magn Reson Imaging. 2017 Oct;26(5):211-218. doi: 10.1097/RMR.0000000000000147. Review.

PMID:
28961570
35.

DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes.

Kuerer HM, Smith BD, Chavez-MacGregor M, Albarracin C, Barcenas CH, Santiago L, Edgerton ME, Rauch GM, Giordano SH, Sahin A, Krishnamurthy S, Woodward W, Tripathy D, Yang WT, Hunt KK.

J Cancer. 2017 Aug 22;8(14):2653-2662. doi: 10.7150/jca.20871. eCollection 2017. Review.

36.

In obesity even young women suffer from urogynecological symptoms.

Brucker J, Wagner I, Rudofsky G, Rauch G, Sohn C, Brocker KA.

Arch Gynecol Obstet. 2017 Nov;296(5):947-956. doi: 10.1007/s00404-017-4514-6. Epub 2017 Sep 5.

PMID:
28875234
37.

Development and validation of a rapid and robust method to determine visceral adipose tissue volume using computed tomography images.

Parikh AM, Coletta AM, Yu ZH, Rauch GM, Cheung JP, Court LE, Klopp AH.

PLoS One. 2017 Aug 31;12(8):e0183515. doi: 10.1371/journal.pone.0183515. eCollection 2017.

38.

Choice of futility boundaries for group sequential designs with two endpoints.

Schüler S, Kieser M, Rauch G.

BMC Med Res Methodol. 2017 Aug 8;17(1):119. doi: 10.1186/s12874-017-0387-4.

39.

Inter-rater reliability and double reading analysis of an automated three-dimensional breast ultrasound system: comparison of two independent examiners.

Maier A, Heil J, Lauer A, Harcos A, Schaefgen B, von Au A, Spratte J, Riedel F, Rauch G, Hennigs A, Domschke C, Schott S, Rom J, Schuetz F, Sohn C, Golatta M.

Arch Gynecol Obstet. 2017 Sep;296(3):571-582. doi: 10.1007/s00404-017-4473-y. Epub 2017 Jul 26.

PMID:
28748340
40.

Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast Conservation.

Tadros AB, Smith BD, Shen Y, Lin H, Krishnamurthy S, Lucci A, Barcenas CH, Hwang RF, Rauch G, Santiago L, Strom EA, DeSnyder SM, Yang WT, Black DM, Albarracin CT, Chavez-MacGregor M, Hunt KK, Kuerer HM.

Ann Surg. 2019 Jan;269(1):150-157. doi: 10.1097/SLA.0000000000002439.

PMID:
28742682
41.

A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.

Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A Jr, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT.

Ann Surg. 2018 May;267(5):946-951. doi: 10.1097/SLA.0000000000002313.

42.

Reciprocal Interaction of 24-Hour Blood Pressure Variability and Systolic Blood Pressure on Outcome in Stroke Thrombolysis.

Kellert L, Hametner C, Ahmed N, Rauch G, MacLeod MJ, Perini F, Lees KR, Ringleb PA; SITS Investigators.

Stroke. 2017 Jul;48(7):1827-1834. doi: 10.1161/STROKEAHA.117.016876. Epub 2017 May 25.

PMID:
28546325
43.

Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.

Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A Jr, Caudle AS, DeSnyder SM, Teshome M, Barcenas CH, Miggins M, Adrada BE, Moseley T, Hwang RF, Hunt KK, Kuerer HM.

JAMA Surg. 2017 Jul 1;152(7):665-670. doi: 10.1001/jamasurg.2017.0562. Erratum in: JAMA Surg. 2017 Jul 1;152(7):708.

44.

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.

Fremd C, Hack CC, Schneeweiss A, Rauch G, Wallwiener D, Brucker SY, Taran FA, Hartkopf A, Overkamp F, Tesch H, Fehm T, Hadji P, Janni W, Lüftner D, Lux MP, Müller V, Ettl J, Belleville E, Sohn C, Schuetz F, Beckmann MM, Fasching PA, Wallwiener M.

Arch Gynecol Obstet. 2017 May;295(5):1239-1245. doi: 10.1007/s00404-017-4348-2. Epub 2017 Mar 22.

PMID:
28331996
45.

Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).

Kasper B, Gruenwald V, Reichardt P, Bauer S, Rauch G, Limprecht R, Sommer M, Dimitrakopoulou-Strauss A, Pilz L, Haller F, Hohenberger P.

Eur J Cancer. 2017 May;76:60-67. doi: 10.1016/j.ejca.2017.02.001. Epub 2017 Mar 8.

PMID:
28282612
46.

Imaging-Concordant Benign MRI-Guided Vacuum-Assisted Breast Biopsy May Not Warrant MRI Follow-Up.

Huang ML, Speer M, Dogan BE, Rauch GM, Candelaria RP, Adrada BE, Hess KR, Yang WT.

AJR Am J Roentgenol. 2017 Apr;208(4):916-922. doi: 10.2214/AJR.16.16576. Epub 2017 Jan 31.

PMID:
28140609
47.

Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.

Ho JC, Allen PK, Bhosale PR, Rauch GM, Fuller CD, Mohamed AS, Frumovitz M, Jhingran A, Klopp AH.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):546-553. doi: 10.1016/j.ijrobp.2016.11.015. Epub 2016 Nov 17.

48.

Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?

Heil J, Schaefgen B, Sinn P, Richter H, Harcos A, Gomez C, Stieber A, Hennigs A, Rauch G, Schuetz F, Sohn C, Schneeweiss A, Golatta M.

Eur J Cancer. 2016 Dec;69:142-150. doi: 10.1016/j.ejca.2016.09.034. Epub 2016 Nov 4.

PMID:
27821317
49.

Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer.

Rauch GM, Adrada BE, Kuerer HM, van la Parra RF, Leung JW, Yang WT.

AJR Am J Roentgenol. 2017 Feb;208(2):290-299. doi: 10.2214/AJR.16.17223. Epub 2016 Nov 3. Review.

PMID:
27809573
50.

Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.

Swanick CW, Castle KO, Vedam S, Munsell MF, Turner LM, Rauch GM, Jhingran A, Eifel PJ, Klopp AH.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):793-800. doi: 10.1016/j.ijrobp.2016.07.035. Epub 2016 Jul 30.

Supplemental Content

Support Center